In February 2015, Sosei acquired 100% of Heptares’ share capital for $180 million in cash consideration and up to $220 million contingent upon the successful progression of the company’s pipeline and platform.
In November 2014, MVM led the merger of AmbioPharm and Ambio to create a leading vertically integrated specialty pharmaceutical company focused on peptides.
Onbone Ltd raises €10m from international investor syndicate for the global launch of its novel casting/splinting products.
AccuVein Inc., have announced that they have signed an exclusive distribution agreement with SinoPharm-UMD to sell the award-winning AccuVein AV400 vein visualization device in China. The China Food and Drug Administration (CFDA) has recently approved the sale of the AccuVein AV400 in China.